Perrigo Co PLC (BSP:P1RG34)
R$ 148.27 0 (0%) Market Cap: 20.23 Bil Enterprise Value: 40.51 Bil PE Ratio: 0 PB Ratio: 0.76 GF Score: 64/100

Perrigo Company PLC at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 17, 2020 / 12:45PM GMT
Release Date Price: R$198.78
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

Great. So good morning, everyone, and thank you for joining the session with Perrigo. My name is Dave Risinger, and I cover both major and specialty pharmaceuticals at Morgan Stanley. And it's very much my pleasure to welcome Perrigo to participate today.

I do need to refer you to a disclaimer. This webcast is only for Morgan Stanley's clients and appropriate Morgan Stanley employees only. It's not for members of the press. If you are a member of the press, please disconnect and reach out separately. Please reference www.morganstanley.com/disclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

I want to apologize for our late start. We will try to run it 5 minutes late to recapture some of the time. So thank you for your patience, everyone, in particular, Murray and Ray. So it's my pleasure to welcome Murray Kessler, President and CEO

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot